Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Mar;69(3):592–595. doi: 10.1038/bjc.1994.108

Diet and subsequent survival in women with breast cancer.

D Ingram 1
PMCID: PMC1968856  PMID: 8123493

Abstract

Our findings from a previous study, that increased consumption of beta-carotene and vitamin C is associated with favourable prognostic indices in patients with breast cancer, have been borne out by our current study of patient survival over a 6-year period. The results of the current study point to beta-carotene consumption as the dietary variable most significantly associated with improved survival. Only one death occurred in the group with the highest consumption of beta-carotene, while there were eight and 12 deaths in the intermediate and lowest groups of consumption respectively. The possible antiproliferative effects of beta-carotene have been recognised for some time, with investigations being focused more recently on its derivative, retinoic acid, which has been found to improve differentiation in many tissues, including cell lines derived from mammary carcinomas. Retinoids have been associated with significant clinical responses in a variety of tumours, and chemoprevention trials using beta-carotene have been undertaken for many malignancies. However, beta-carotene has not yet been used in clinical trials to evaluate its potential for the treatment of breast cancer. A large-scale clinical trial is necessary to determine the effectiveness of beta-carotene in reducing the chances of recurrence of breast cancer, and in preventing the development of new cancers.

Full text

PDF
592

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baghurst K. I., Record S. J. A computerised dietary analysis system for use with diet diaries or food frequency questionnaires. Community Health Stud. 1984;8(1):11–18. doi: 10.1111/j.1753-6405.1984.tb00419.x. [DOI] [PubMed] [Google Scholar]
  2. Fontana J. A., Hobbs P. D., Dawson M. I. Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. Exp Cell Biol. 1988;56(5):254–263. doi: 10.1159/000163488. [DOI] [PubMed] [Google Scholar]
  3. Holm L. E., Callmer E., Hjalmar M. L., Lidbrink E., Nilsson B., Skoog L. Dietary habits and prognostic factors in breast cancer. J Natl Cancer Inst. 1989 Aug 16;81(16):1218–1223. doi: 10.1093/jnci/81.16.1218. [DOI] [PubMed] [Google Scholar]
  4. Howe G. R., Hirohata T., Hislop T. G., Iscovich J. M., Yuan J. M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990 Apr 4;82(7):561–569. doi: 10.1093/jnci/82.7.561. [DOI] [PubMed] [Google Scholar]
  5. Hunter D. J., Manson J. E., Colditz G. A., Stampfer M. J., Rosner B., Hennekens C. H., Speizer F. E., Willett W. C. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med. 1993 Jul 22;329(4):234–240. doi: 10.1056/NEJM199307223290403. [DOI] [PubMed] [Google Scholar]
  6. Ingram D. M., Roberts A., Nottage E. M. Host factors and breast cancer growth characteristics. Eur J Cancer. 1992;28A(6-7):1153–1161. doi: 10.1016/0959-8049(92)90477-j. [DOI] [PubMed] [Google Scholar]
  7. Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M. P., Durand B., Lanotte M., Berger R., Chambon P. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 1992 Feb;11(2):629–642. doi: 10.1002/j.1460-2075.1992.tb05095.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kelloff G. J., Boone C. W., Malone W. F., Steele V. E. Chemoprevention clinical trials. Mutat Res. 1992 Jun;267(2):291–295. doi: 10.1016/0027-5107(92)90073-b. [DOI] [PubMed] [Google Scholar]
  9. Lippman S. M., Kavanagh J. J., Paredes-Espinoza M., Delgadillo-Madrueño F., Paredes-Casillas P., Hong W. K., Holdener E., Krakoff I. H. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1992 Feb 19;84(4):241–245. doi: 10.1093/jnci/84.4.241. [DOI] [PubMed] [Google Scholar]
  10. Lippman S. M., Parkinson D. R., Itri L. M., Weber R. S., Schantz S. P., Ota D. M., Schusterman M. A., Krakoff I. H., Gutterman J. U., Hong W. K. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst. 1992 Feb 19;84(4):235–241. doi: 10.1093/jnci/84.4.235. [DOI] [PubMed] [Google Scholar]
  11. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta. 1980 Mar 12;605(1):33–91. doi: 10.1016/0304-419x(80)90021-9. [DOI] [PubMed] [Google Scholar]
  12. Potischman N., McCulloch C. E., Byers T., Nemoto T., Stubbe N., Milch R., Parker R., Rasmussen K. M., Root M., Graham S. Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Clin Nutr. 1990 Nov;52(5):909–915. doi: 10.1093/ajcn/52.5.909. [DOI] [PubMed] [Google Scholar]
  13. Sporn M. B., Roberts A. B. Role of retinoids in differentiation and carcinogenesis. Cancer Res. 1983 Jul;43(7):3034–3040. [PubMed] [Google Scholar]
  14. Veronesi U., De Palo G., Costa A., Formelli F., Marubini E., Del Vecchio M. Chemoprevention of breast cancer with retinoids. J Natl Cancer Inst Monogr. 1992;(12):93–97. [PubMed] [Google Scholar]
  15. Verreault R., Brisson J., Deschênes L., Naud F., Meyer F., Bélanger L. Dietary fat in relation to prognostic indicators in breast cancer. J Natl Cancer Inst. 1988 Aug 3;80(11):819–825. doi: 10.1093/jnci/80.11.819. [DOI] [PubMed] [Google Scholar]
  16. Warrell R. P., Jr, Frankel S. R., Miller W. H., Jr, Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med. 1991 May 16;324(20):1385–1393. doi: 10.1056/NEJM199105163242002. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES